290650 · L&C BIO Co., Ltd.
70100.00
KRWUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
KRW1.73T
PE
0.00
EV/EBITDA
131.2
DIV Yield
0.1%
Payout Ratio
0%
MQV Rating
4Weak
As at 16/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Big Candle
- Consensus Cheap
- Fakey Shakey - Short
- HALO 200
- HALO All
- HALO Price Momentum
- HALO Small
- Near Resistance
- Recent Earnings downgrade
Key Fundamentals
EPS 3 yr Growth
-3001.10%
EBITDA Margin
13.50%
Operating Cashflow
₩12,565m
Free Cash Flow Return
4.90%
ROIC
-53.80%
Interest Coverage
2.00
Quick Ratio
0.40
Performance
52 weeks range
Low 40761.12 - 120881.12
Trade Value (12mth)
US$5,236,824.00
1 week
-2.74%
1 month
19.49%
YTD
-6.04%
1 year
8.58%
All time high
120881.00
Additional Data
Shares Outstanding (Fully Diluted)
27m
HALO Sector
Healthcare
Next Company Report Date
22-Mar-27
Next Ex Dividend Date
29-Dec-25
Next Dividend Pay Date
15-Apr-26
Reporting Currency
KRW
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Weak
Garp
Neutral
Mqv Small
Weak
Momentum
Price
Very Strong
Earnings
Very Weak
Growth
Earnings
Neutral
Dividends
Neutral
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Hwan-Chul Lee | Individual |
| Nau IB Capital Co. Ltd. (Venture Capital) | Operating Division |
| L&C BIO Co., Ltd. | Public Company |
| L&C Bio Co., Ltd. ESOA | Emp Stk Ownership Plan |
| Ki-min Kim | Individual |
